Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination therapy used primarily for the management of status asthmaticus and severe asthma exacerbations that are resistant to conventional treatments. This combination leverages multiple complementary mechanisms to address severe bronchospasm.\ \ - **Ketamine** functions as an NMDA receptor antagonist that reduces inflammation and induces bronchodilation when nebulized[1]. It has proven effective in managing asthma due to its bronchodilator properties, primarily by stimulating nitric oxide and catecholamine release[1].\ \ - **Magnesium sulfate** relaxes smooth muscles by regulating calcium influx, which alleviates bronchospasm and enhances bronchodilation[1][6]. It can be administered intravenously or via nebulization, with both routes showing efficacy in improving respiratory parameters[6].\ \ - **Salbutamol** (also known as albuterol) is a β2 adrenergic agonist that provides rapid bronchodilation. When combined with magnesium sulfate in nebulized form, it has shown enhanced clinical improvement in acute asthma compared to either agent alone[10].\ \ - **Sevoflurane** is a fluorinated methyl isopropyl ether that can be used in refractory cases of status asthmaticus. It produces dose-dependent effects on the circulatory system and has been documented to improve outcomes in patients with severe asthma that fails to respond to other interventions[2].\ \ ## Clinical Evidence\ \ Studies have demonstrated that these agents can be used in various combinations to enhance treatment efficacy:\ \ - The combination of ketamine or magnesium sulfate with standard asthma therapies enhances treatment efficacy, especially for corticosteroid-resistant cases[1].\ \ - Nebulized ketamine has been shown to significantly improve Peak Expiratory Flow Rate (PEFR) in steroid-resistant asthma exacerbations[6].\ \ - Intravenous magnesium sulfate has shown promising results in treatment of severe steroid-resistant asthma[6].\ \ - Nebulized magnesium sulfate alone or combined with salbutamol has demonstrated clinically significant bronchodilator effects in acute asthma[10].\ \ - Sevoflurane has been reported as a potentially effective management strategy for adults with status asthmaticus, with most patients showing improvement after its initiation[2].\ \ The therapeutic efficacy of ketamine can be increased when used in combination with magnesium sulfate[5], and similarly, the therapeutic efficacy of sevoflurane can be increased when used in combination with magnesium sulfate[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ketamine + magnesium sulfate + salbutamol + sevoflurane.